[CYCC] YoY Quarter Result on 31-Mar-2021 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-May-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -24.04%
YoY- -185.08%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 29 0 0 0 0 0 0 -
PBT -7,225 -7,124 -5,246 -4,165 -1,510 -2,110 -1,531 29.48%
Tax -4,279 -1,320 -1,138 -687 -290 -268 -182 69.17%
NP -2,946 -5,804 -4,108 -3,478 -1,220 -1,842 -1,349 13.88%
Tax Rate - - - - - - - -
Total Cost 2,975 5,804 4,108 3,478 1,220 1,842 1,349 14.07%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -10,158.62 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -2.27 -6.94 -0.41 -0.50 -1.42 -2.70 -2.25 0.14%
EPS Diluted -2.27 -6.94 -0.41 -0.50 -1.42 -2.70 -2.25 0.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.